Novel Non-Protein Biomarkers for Early Detection of Hepatocellular Carcinoma

作     者：Ghassan K.Abou-Alfa Lin Wu Augusto Villanueva Ghassan K.Abou-Alfa;Lin Wu;Augusto Villanueva

作者机构：Memorial Sloan Kettering Cancer CenterNew York CityNY 10065USA Weill Medical CollegeCornell UniversityNew York CityNY 10065USA Berry Oncology CorporationBeijing 102200China Division of Liver DiseasesDivision of Hematology/Medical OncologyLiver Cancer ProgramDepartment of MedicineTisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew York CityNY 10029USA 

出 版 物：《Engineering》 (工程（英文）)

年 卷 期：2021年第7卷第10期

页      面：1369-1374页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：Hepatocellular carcinoma Early detection Biomarkers Liquid biopsy 

摘      要：Early detection of hepatocellular carcinoma(HCC)while in its early stages is critical for reducing HCC mortality in high-risk ***,highly sensitive and specific surveillance biomarkers for early-stage HCC detection are still *** recent years,great efforts have been made to research tumor-derived molecular features that are detectable in circulation,such as circulating tumor deoxyribonucleic acid and circulating tumor ribonucleic acid,in order to explore their potential as noninvasive biomarker candidates in many tumor *** this review,we summarize current studies on these new approaches and their application in early HCC detection.